6th-January-2021

Molecular subtyping of Alzheimers disease using RNA sequencing data reveals novel mechanisms and targets

---

21st-December-2020

Transcriptomic organization of the human brain in post-traumatic stress disorder

---

13th-December-2020

New blood test reveals mBDNF lower in people with depression or bipolar disorder than in healthy controls

---

24th-November-2020

Multi-Omic Analysis Reveals Possible Treatment for Late-Onset Alzheimer Disease

---

18th-November-2020

Genetic link to molecular events that precede symptoms in Alzheimer disease

---

4th-November-2020

Two doses of the psychedelic substance psilocybin produce rapid and large reductions in depressive symptoms

---

12th-October-2020

Vascular Function, Tau, and Alzheimers

---

9th-October-2020

Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy

---

6th-October-2020

Increasing PICALM expression reverses endocytic defects in APOE4 astrocytes in AD

---

1st-October-2020

P11 deficiency increases stress reactivity

---

28th-September-2020

Epigenetic alterations associated with Alzheimer’s disease

---

17th-September-2020

Function of WFS1 and WFS2 in the Central Nervous System

---

11th-September-2020

Cerebral Fructose Metabolism as a Potential Mechanism Driving AD

---

2nd-September-2020

A mechanism by which inflammation affects the generation of amyloid-beta in AD

---

22nd-August-2020

Anti-inflammatory IL-10 administration to rescue depression-related learning and memory deficits in mice.

---